2-Chloro-5-fluoropyridine-3,4-diamine, 95.0%, 250mg

3-ETHYL-5-HYDROXY-1,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-2-ONE, 95.0%, 1g

Allyl piperazine-1-carboxylate hydrochloride, 95.0%, 1g

Methyl 5-methoxy-4-((4-methoxybenzyl)oxy)-2-nitrobenzoate, 97.0%, 5g

3-bromo-2-methyl-1,8-naphthyridine, 95.0%, 500mg

4-Methoxybenzonitrile, 99.00%, 10g

3'-Chloro-5'-fluoroacetophenone, 97.0%, 5g

Tert-butyl n-[1-(5-cyanopyridin-2-yl)piperidin-4-yl]carbamate, 95%, 250mg

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide, 98.0%, 5g

(1-Ethyl-3,5-dimethyl-1H-pyrazol-4-yl)-methanol, 95.0%, 10g

Isoquinoline-7-carbonitrile, 95.0%, 250mg

3-(4-Bromophenyl)-5-methyl-1,2,4-oxadiazole, 95.0%, 25g